Publications by authors named "Luca Pastorelli"

Claim this Profile
2
288 ENMC International Workshop. Towards better diagnosing, understanding and treating gastrointestinal symptoms in myotonic dystrophy: extended insights and practical recommendations. 16-18 May 2025, Hoofddorp, the Netherlands.
Saskia Scholten, Janel A M Peterson, Lynn B Orriëns, Luca Pastorelli, Giovanni Meola

Neuromuscul Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dual Role of ACE2 in IBD: Balancing SARS-CoV-2 Susceptibility and Gut Homeostasis.
Laura Francesca Pisani, Guglielmo Albertini Petroni, Luca Pastorelli, Chiara Porta

Inflamm Bowel Dis· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning-the IG-IBD LIVE study.
Daniela Pugliese, Giuseppe Privitera, Nicola Cersullo, Harsh Bordekar, Federica Crispino, Luca Pastorelli

Dig Liver Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower Expression of SARS-CoV-2 Host Cell Entry Genes in the Intestinal Mucosa of IBD Patients With Quiescent or Mildly Active Disease.
Laura Francesca Pisani, Gugliemo Albertini Petroni, Giorgia Crespi, Silvia Mola, Maria Laura Annunziata, Luca Pastorelli

Inflamm Bowel Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Disease-Related Malnutrition and Micronutrients Deficit in Patients with Inflammatory Bowel Disease: A Multicentric Cross-Sectional Study by the GSMII (Inflammatory Bowel Disease Study Group).
Chiara Viganò, Andrea Palermo, Giacomo Mulinacci, Lorena Pirola, Alessandra Losco, Luca Pastorelli

Inflamm Bowel Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe azathioprine-induced liver injury 22 months after initiation of treatment.
Giovanni Cataletti, Fabrizio Santagata, Luca Pastorelli, Pier Maria Battezzati

Drug Ther Bull· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves.
Cristina Bezzio, Marta Vernero, Stefania Costa, Alessandro Armuzzi, Gionata Fiorino, Luca Pastorelli

BMC Gastroenterol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Enabled Histological Prediction of Remission or Activity and Clinical Outcomes in Ulcerative Colitis.
Marietta Iacucci, Tommaso Lorenzo Parigi, Rocio Del Amor, Pablo Meseguer, Giulio Mandelli, Luca Pastorelli

Gastroenterology· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-33: Friend or Foe in Gastrointestinal Tract Cancers?
Laura Francesca Pisani, Isabella Teani, Maurizio Vecchi, Luca Pastorelli

Cells· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease.
Marco Vincenzo Lenti, Maria Lia Scribano, Livia Biancone, Rachele Ciccocioppo, Daniela Pugliese, Luca Pastorelli

Front Med (Lausanne)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into Mesalazine Use in Clinical Practice of Young Gastroenterologists.
Olga Maria Nardone, Giovanni Marasco, Loris Riccardo Lopetuso, Giammarco Mocci, Luca Pastorelli

J Clin Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for inadequate bowel preparation in patients using high- and low-volume cleansing products.
Vincenzo Occhipinti, Paola Soriani, Sara Vavassori, Maria Laura Annunziata, Francesco Bagolini, Luca Pastorelli

Eur J Gastroenterol Hepatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison study.
Andrea Cassinotti, Nicolò Mezzina, Annalisa De Silvestri, Dhanai Di Paolo, Marco Vincenzo Lenti, Luca Pastorelli

Eur J Gastroenterol Hepatol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe azathioprine-induced liver injury 22 months after initiation of treatment.
Giovanni Cataletti, Fabrizio Santagata, Luca Pastorelli, Pier Maria Battezzati

BMJ Case Rep· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constrained multiple instance learning for ulcerative colitis prediction using histological images.
Rocío Del Amor, Pablo Meseguer, Tommaso Lorenzo Parigi, Vincenzo Villanacci, Adrián Colomer, Luca Pastorelli

Comput Methods Programs Biomed· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study.
Francesca Ferretti, Maria Camilla Monico, Rosanna Cannatelli, Stefania Carmagnola, Marco Vincenzo Lenti, Luca Pastorelli

Front Med (Lausanne)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study.
Daniela Pugliese, Giuseppe Privitera, Federica Crispino, Nicolò Mezzina, Fabiana Castiglione, Luca Pastorelli

Aliment Pharmacol Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring mucosal healing and predicting clinical outcomes and its applicability in an artificial intelligence system.
Xianyong Gui, Alina Bazarova, Rocìo Del Amor, Michael Vieth, Gert de Hertogh, Luca Pastorelli

Gut· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Gian Eugenio Tontini, Lorenzo Dioscoridi, Alessandro Rimondi, Paolo Cantù, Flaminia Cavallaro, Luca Pastorelli

Endosc Int Open· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PICaSSO virtual electronic chromendoscopy accurately reflects combined endoscopic and histological assessment for prediction of clinical outcomes in ulcerative colitis.
Olga Maria Nardone, Alina Bazarova, Pradeep Bhandari, Rosanna Cannatelli, Marco Daperno, Luca Pastorelli

United European Gastroenterol J· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-kB pathway is involved in microscopic colitis pathogenesis.
Laura Francesca Pisani, Gianeugenio Tontini, Maurizio Vecchi, Giorgio Alberto Croci, Luca Pastorelli

J Int Med Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study.
Stefano Mazza, Nicole Piazza O Sed, Francesco Simone Conforti, Alberto Fascì, Alessandro Rimondi, Luca Pastorelli

Clin Transl Sci· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study.
Cristina Bezzio, Alessandro Armuzzi, Federica Furfaro, Sandro Ardizzone, Monica Milla, Luca Pastorelli

Aliment Pharmacol Ther· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: The Dark Side of Microscopic Colitis.
Laura Francesca Pisani, Gian Eugenio Tontini, Luca Pastorelli

Front Med (Lausanne)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of high and low-volume bowel preparation compared: A real-life single-blinded large-population study.
Vincenzo Occhipinti, Paola Soriani, Francesco Bagolini, Valentina Milani, Emanuele Rondonotti, Luca Pastorelli

World J Gastrointest Endosc· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis